GlassScriptPhysician profile
Paul X Benedetto
NPI 1134393028
$96,343.90
in general payments reported to CMS, 2019-2025
32 companies · $24.93 in 2025
The $24.93 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80K · 2020: $16K · 2021: $85.07 · 2022: $298 · 2024: $15.22 · 2025: $24.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $74,035.49 | 2019-2020 | |
| Ipsen Innovation | $9,813.20 | 2019 | |
| Galderma Laboratories, L.P. | $9,628.62 | 2019-2020 | |
| Organogenesis INC. | $1,075.21 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $173.58 | 2019 | |
| Janssen Biotech, INC. | $155.53 | 2019-2021 | |
| Vector Surgical, LLC | $150.00 | 2022 | |
| Amgen INC. | $144.20 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $140.33 | 2019 | |
| Dermira, INC. | $107.90 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $98.47 | 2019-2020 | |
| Merz North America, INC. | $89.18 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $82.76 | 2019 | |
| Lilly USA, LLC | $73.40 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $73.06 | 2019-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $69.96 | 2019-2022 | |
| Celgene Corporation | $69.33 | 2019 | |
| Pfizer INC. | $61.84 | 2019 | |
| Vyne Pharmaceuticals INC. | $36.34 | 2020 | |
| Merck Sharp & Dohme LLC | $35.43 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.06 | 2019-2020 | |
| Stemline Therapeutics INC. | $26.40 | 2021 | |
| Boston Scientific Corporation | $24.93 | 2025 | Ams 700 |
| Ucb, INC. | $20.98 | 2019 | |
| Sandoz INC. | $20.21 | 2019 | |
| Biofrontera INC. | $19.98 | 2019 | |
| Kyowa Kirin, INC. | $18.13 | 2021 | |
| Leo Pharma INC. | $17.36 | 2019 | |
| Mayne Pharma Commercial LLC | $14.05 | 2019 | |
| Mission Pharmacal Company | $13.78 | 2019 | |
| Misonix INC | $12.69 | 2020 | |
| Journey Medical Corporation | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Benedetto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.